The General Meeting of Oncodesign Authorises the Allocation

Each Oncodesign shareholder will receive one OPM share for one ONCODESIGN share held Regulatory News: Oncodesign's (Paris:ALONC) General Meeting held on September 30, 2022, authorised the

Related Keywords

France , Arthur Rouill , Mathilde Bohin , Philippe Genne , Euronext , Each Oncodesign , General Meeting , Euronext Access , Oncodesign Precision Medicine , Precision Medicine , Euronext Growth Market , Artificial Intelligence , General , Meeting , Oncodesign , Authorises , Allocation , Precision , Medicine , Hares , Shareholders ,